Our results show that HDL in people with T2D loses its endothelium protective properties independent of HDL-C levels and the loss of ability to stimulate eNOS activation is associated with decreased levels of S1P and increased circulating P-selectin, a marker of endothelial dysfunction. The gene discussed is SELP; the disease is endothelial dysfunction.